Different Doses of ZED1227 vs. Placebo in NAFLD

NCT05305599 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

NAFLD
Liver Fibrosis

Interventions

DRUG: ZED1227
DRUG: Placebo

Sponsor

Dr. Falk Pharma GmbH